Sort
48,018 grants matching “immunotherapy”
Characterizing head and neck tumor neoantigensand T cells: looking beyond the usual suspects
$470,649John B Sunwoo · Stanford University · R01 · FY2021 · DE
Post-translation regulation of Listeria monocytogenes virulence factors
$470,646Nancy Freitag · University Of Illinois At Chicago · R01 · FY2019 · AI
Project 2: Druggable dependencies in diffuse midline gliomas
$470,606Daphne A. Haas-Kogan · Brigham And Women'S Hospital · P50 · FY2025 · CA
Innovative Tools for Chemical Synthesis: Metal-Hydride Catalysis, Medicinal Motifs, and Molecular Probes
$470,580Vy M Dong · University Of California-Irvine · R35 · FY2025 · GM
Renalase inhibition for treatment of unresectable melanoma
$470,539Harriet M Kluger · Yale University · R01 · FY2019 · CA
Pharmacokinetics and Immunodynamics of Immune stimulating chemotherapeutic nanoparticles for TB
$470,531Jessica L Reynolds · State University Of New York At Buffalo · R01 · FY2020 · AI
Developing clinical, immunologic and radiographic tools to measure the clinical effect of immunotherapy in biochemically recurrent prostate cancer
$470,524Philip W Kantoff · Sloan-Kettering Inst Can Research · U01 · FY2016 · CA
BITE (Bat Immunology Training and Education) - an undergraduate experiential program for developing the next generation of One Health scientists
$470,518Richard Allen White III · University Of North Carolina Charlotte · R15 · FY2024 · AI
Tumor microenvironment: Impact on T cell tumor-targeting, activation and survival
$470,514Ronald G Blasberg · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA
Development of mAb therapeutics against biothreat and emerging diease agents
$470,485Thomas Briese · Columbia University Health Sciences · U54 · FY2011 · AI
Targeting autophagy to enhance immune checkpoint inhibition
$470,485Ravi K Amaravadi · Wistar Institute · P50 · FY2021 · CA
Project 1 - Modulation of Tolerance and Autoimmunity by Inhibitory Receptors
$470,427Arlene H Sharpe · University Of Pittsburgh At Pittsburgh · P01 · FY2020 · AI
The Evaluation of Novel Therapeutics for Genitourinary Malignancies
$470,418William Laurence Dahut · Division Of Clinical Sciences - Nci · ZIA · FY2019 · CA
T-Cell Responses Predict Influenza Risk in Older Adults
$470,418Janet E. McElhaney · University Of Connecticut Sch Of Med/Dnt · R01 · FY2009 · AI
Gain-of-function complement activators as a new class of immunotherapeutic molecules
$470,349Ruben Martinez Barricarte · Vanderbilt University Medical Center · R01 · FY2024 · CA
Duke-UNC Chapel Hill Immunotherapy Training Grant
$470,297Jonathan Stuart Serody · Univ Of North Carolina Chapel Hill · T32 · FY2017 · CA
Mathematical Model-Guided Adoptive Immunotherapy in Bladder Cancer
$470,293Katarzyna Anna Rejniak · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2021 · CA
Research Training in Academic Medical Oncology
$470,270Michael Davies · University Of Tx Md Anderson Can Ctr · T32 · FY2017 · CA
Modulation of asparagine bioavailability and stress response signaling to enhance T cell robustness and maximize immunotherapy
$470,246Ruoning Wang · Research Inst Nationwide Children'S Hosp · R01 · FY2022 · CA
Modulation of asparagine bioavailability and stress response signaling to enhance T cell robustness and maximize immunotherapy
$470,246Ruoning Wang · Research Inst Nationwide Children'S Hosp · R01 · FY2023 · CA
CAREER: The next generation intracellular delivery device for immunotherapy: The integration between ultrasonic transducer and microfluidic chip (UXuChip)
$470,184Sangpil Yoon · University Of Oklahoma Norman Campus · · FY2022 · ENG
Targeting TERT in Melanoma
$470,176Jessie Villanueva · Wistar Institute · R01 · FY2020 · CA
Microbiome Function in Atopic Dermatitis
$470,159Richard L Gallo · University Of California, San Diego · U01 · FY2024 · AI
Preclinical development and clinical monitoring of adoptive immune therapy
$470,080Frances Hakim · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA
Dual-pronged nano-drug delivery using plant virus-like particles
$470,066Nicole Franziska Steinmetz · Case Western Reserve University · R01 · FY2017 · CA